Summary Background Clinical practice guidelines (CPGs) developed with rigorous methods
can help optimize clinical care for patients with psoriasis. Objectives To conduct an updated …

Background Previous observational studies have found an association between
inflammatory bowel disease (IBD) and psoriasis. Using the mendelian randomization (MR) …

Background Systemic immunomodulatory agents are indicated in the treatment of moderate-
to-severe plaque psoriasis and psoriatic arthritis. Perioperative use of these medications …

Objectives Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, were evaluated in
a 6-month, double-blind, phase 3 study in Chinese patients with active (polyarthritic) …

Background and purpose Previous studies reported conflicting results about the risk of
ischemic stroke associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs) in …

Psoriatic disease is a chronic inflammatory disorder with skin and joint manifestations. Due
to the persistent inflammatory state exhibited by patients with psoriasis, multiple systemic …

Rheumatoid arthritis (RA) can independently increase the risk of stroke, affecting both young
and adult RA patients. Recent attention has been drawn to the association between stroke …

With the advent of classification criteria for psoriatic arthritis (PsA) and axial spondyloarthritis
(axSpA), patients with axial manifestations associated with psoriasis, initially described in …

The prevention of joint deformity is among the most important treatment goals of psoriatic
arthritis. Some biologics disease-modifying antirheumatic drugs (bDMARDs) have been …

Background The relation between psoriasis and hearing loss has been unclear. Objective
To investigate the association of psoriasis with hearing loss. Methods We searched …